SCHEMBL27253275

SCHEMBL27253275

Cc1cc(-c2cc3ccccc3cn2)cc(O)c1C(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ IDO1 P14902 2/20 0.41
▸ TDO2 P48775 2/20 0.41
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2A6 P11509 1/20 0.40
▸ MIF P14174 1/20 0.36
▸ LDHA P00338 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ CDK4 P11802 1/20 0.35
▸ CCNB1 P14635 1/20 0.35
▸ CCND1 P24385 1/20 0.35
▸ CCNE1 P24864 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ AHR P35869 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ BTK Q06187 1/20 0.35
▸ GRM4 Q14833 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24204595 0.91 NPC1 (0.50) NPC1RAB9AIDO1TDO2CYP1A2
SCHEMBL30365932 0.91 NPC1 (0.50) NPC1RAB9AIDO1TDO2CYP1A2
SCHEMBL27253072 0.90 NPC1 (0.51) NPC1RAB9AIDO1TDO2CYP1A2
SCHEMBL31010848 0.86 NPC1 (0.46) NPC1RAB9AIDO1TDO2CYP1A2
SCHEMBL31010855 0.85 NPC1 (0.47) NPC1RAB9AIDO1TDO2CYP1A2
SCHEMBL25522191 0.80 NPC1 (0.50) NPC1RAB9AIDO1TDO2CYP1A2
SCHEMBL27033433 0.78 NPC1 (0.41) NPC1RAB9AIDO1TDO2MIF
SCHEMBL26874136 0.78 NPC1 (0.44) NPC1RAB9AIDO1TDO2CYP1A2
SCHEMBL27033328 0.78 NPC1 (0.41) NPC1RAB9AIDO1TDO2MIF
SCHEMBL31010850 0.77 NPC1 (0.51) NPC1RAB9AIDO1TDO2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024050434-A1 ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR MEDIATED DISEASES Dermavant Sciences GmbH (CH) 2024-03-07 — — WO disclosed
Send feedback